Goehlert & Associates offers a wide range of medical - legal professional services, from simple document review and second opinion to detailed ongoing litigation support / expert consulting services. Fairness, integrity and honesty are the core business values. Contact us for a free consultation on how we can become your outsourced litigation support and medical case review department. We can also assist you and your business in education, research and delivery of medical and ancillary biotechnology expertise.
Services Offered: Custom solutions to your most difficult and most urgent medical legal, quality assurance and utilization review questions requiring trusted, unbiased medical and biotechnical expertise.
Goehlert & AssociatesPrinciplesof Business
1.Integrity— G&A will conduct its business with integrity.
2.Skill, care and diligence— G&A will conduct its business with due skill, care and diligence. 3.Management and control— G&A will take reasonable care to organize and control its affairs responsibly and effectively, with adequate risk management systems. 4.Financial prudence— G&A will maintain adequate financial resources. 5.Market conduct— G&A will observe proper standards of market conduct. 6.Customers’ interests— G&A will pay due regard to the interests of its customers and treat them fairly. 7.Communications with clients— G&A will pay due regard to the information needs of its clients and communicate information to them in a way which is clear, fair and not misleading. 8.Conflicts of interest— G&A will manage conflicts of interest fairly, both between itself and its customers and between a customer and another client. 9.Customers—relationships of trust— G&A will take reasonable care to ensure the suitability of its advice and discretionary decisions for any customer who is entitled to rely upon its judgment. 10.Clients’ assets— G&A will arrange adequate protection for clients’ assets, documents, electronic records etc. when it is responsible for them. 11.Relations with regulators— G&A will deal with regulators in an open and co-operative way and will disclose to the regulator anything non-confidential relating to the firm of which the regulator would reasonably expect notice.